MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$324,411
Unit: Dollar
Positive Cash Flow Breakdown
(gain) loss on derivative instru...
Proceeds from issuance of common...
Accounts payable
Others
Negative Cash Flow Breakdown
Net loss from continuing operati...
Prepaid expense and other assets
Operating lease liability
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss from continuing operations
-77,646,737
-4,264,311
Depreciation and amortization
32,612
65,222
Amortization of operating lease right-of-use assets
141,982
271,099
Non-cash write off of accounts payable and related accrued expenses
0
-676,678
(gain) loss on derivative instruments
74,366,000
0
Vesting expense
371,335
0
Issuance of shares to non-employees
133,333
66,667
Loss on disposal of property and equipment
0
-
Accounts receivable
3,052
-11,197
Inventories
-4,717
-3,054
Prepaid expense and other assets
273,341
297,818
Accounts payable
1,371,226
511,791
Accrued expenses and other
-7,701
371,361
Contract liabilities
-2,500
-75,000
Operating lease liability
-141,739
-267,216
Other long-term liabilities
0
-
Net cash (used in) continuing operating activities
-1,653,865
-4,280,632
Purchase of property and equipment
0
0
Net cash (used in) continuing investing activities
0
0
Proceeds from issuance of common stock and warrants
1,444,044
3,165,365
Costs to issue common stock and warrants
38,058
202,820
Proceeds from issuance of financing note payable
0
264,048
Repayment of note payable
76,674
0
Net cash provided by continuing financing activities
1,329,312
3,226,593
Net cash provided by (used in) operating activities
142
200,444
Net cash provided by (used in) investing activities
0
625,000
Net cash provided by (used in) financing activities
0
0
Net cash provided by (used in) discontinued operations
142
825,444
Net (decrease) in cash
-324,411
-228,595
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock and...
$1,444,044
Net cash provided by
(used in) operating...
$142
Net cash provided by
continuing financing...
$1,329,312
Net cash provided by
(used in)...
$142
Canceled cashflow
$114,732
Net (decrease) in
cash
-$324,411
Canceled cashflow
$1,329,454
(gain) loss on
derivative instruments
$74,366,000
Accounts payable
$1,371,226
Vesting expense
$371,335
Amortization of operating
lease right-of-use...
$141,982
Issuance of shares to
non-employees
$133,333
Depreciation and
amortization
$32,612
Inventories
-$4,717
Repayment of note payable
$76,674
Costs to issue common
stock and warrants
$38,058
Net cash (used in)
continuing operating...
-$1,653,865
Canceled cashflow
$76,421,205
Net loss from
continuing operations
-$77,646,737
Prepaid expense and
other assets
$273,341
Operating lease liability
-$141,739
Accrued expenses and
other
-$7,701
Accounts receivable
$3,052
Contract liabilities
-$2,500
Buy us a coffee
Predictive Oncology Inc. (POAI)
Predictive Oncology Inc. (POAI)